EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Esomeprazole treatment targeting sFLT-1 signaling in preeclampsia improves placental and fetal outcome in mice

Beatrix Reisch, Lilo Valerie Wölk, Alina Edinger, Rainer Kimmig, Antonella Iannaccone, Alexandra Gellhaus

Placenta · 2026-08 · 182 · 229-238

DOI: 10.1016/j.placenta.2026.06.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Placenta, 2026-08. Verfasst von Beatrix Reisch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, University Hospital Essen, Germany. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-1, Pre-Eclampsia, Placenta, Esomeprazole. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Duisburg-Essen, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Preeclampsia (PE) is one of the leading causes of maternal and infant mortality. Increase of soluble fms-like tyrosine kinase-1 (sFLT-1) is thought to be a key player in pathophysiology. Since preclinical studies showed therapeutical effects of esomeprazole (Eso), we hypothesized treatment may target sFLT-1 in PE. METHODS: Using the PE/FGR (fetal growth restriction) model with systemic human sFLT-1 overexpression, mice were treated with Eso or vehicle. We analyzed dams, fetal and placental tissues regarding sFLT-1 at day 18.5 dpc and determined hypoxia of placentas using the marker pimonidazole. RESULTS: Eso led to a trend of decrease in sFLT-1 serum levels. As shown previously by us sFLT-1 increase resulted in different severity levels of FGR. Exclusive maternal sFLT-1 overexpression (PE wt) fetuses revealed a mild reduction in weights, combined maternal and feto-placental sFLT-1 (PE het) led to strong reductions in weights and non-viability of the fetuses. Upon Eso an improvement in fetal outcome shown by an increased rate of fetal viability and a significant increase in weight of PE het fetuses was observed. Furthermore, upon Eso sFLT-1 (sFLT-i13) mRNA expression significantly decreased in the mesometrial triangle tissue (MT) and in placentas of PE het fetuses and maternal kidneys. A significant decrease of pimonidazole in MT of PE wt fetuses and a trend of decrease in PE het fetuses upon Eso showed less hypoxia in the maternal compartment. DISCUSSION: These results could indicate a potential cytoprotective effect of Eso and an improvement of the hypoxic conditions at the maternal-fetal interface during PE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-1Pre-EclampsiaPlacentaEsomeprazoleFemaleAnimalsPregnancyMiceHumansSignal TransductionFetal Growth RetardationDisease Models, Animal

Stichwörter der Autor:innen

EsomeprazoleFetal growth restrictionHypoxiaPlacentaPreeclampsiasFLT-1

Substanzen

Vascular Endothelial Growth Factor Receptor-1EsomeprazoleFlt1 protein, mouse

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, University Hospital Essen, Germany.
  • Department of Gynecology and Obstetrics, University Hospital Essen, Germany. Electronic address: alexandra.gellhaus@uk-essen.de.

Förderung

  • University of Duisburg-Essen
  • German Research Foundation

Zitieren

APA

Reisch, B., Wölk, L. V., Edinger, A., Kimmig, R., Iannaccone, A., & Gellhaus, A. (2026). Esomeprazole treatment targeting sFLT-1 signaling in preeclampsia improves placental and fetal outcome in mice. Placenta, 182, 229-238. https://doi.org/10.1016/j.placenta.2026.06.021

Vancouver

Reisch B, Wölk LV, Edinger A, Kimmig R, Iannaccone A, Gellhaus A. Esomeprazole treatment targeting sFLT-1 signaling in preeclampsia improves placental and fetal outcome in mice. Placenta. 2026;182:229-238. doi:10.1016/j.placenta.2026.06.021

BibTeX
@article{Reisch2026,
  author = {Reisch, Beatrix and Wölk, Lilo Valerie and Edinger, Alina and Kimmig, Rainer and Iannaccone, Antonella and Gellhaus, Alexandra},
  title = {Esomeprazole treatment targeting sFLT-1 signaling in preeclampsia improves placental and fetal outcome in mice},
  journal = {Placenta},
  year = {2026},
  volume = {182},
  pages = {229--238},
  doi = {10.1016/j.placenta.2026.06.021}
}
Kostenlos starten →